<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04367220</url>
  </required_header>
  <id_info>
    <org_study_id>REB13-0902</org_study_id>
    <nct_id>NCT04367220</nct_id>
  </id_info>
  <brief_title>Cardiovascular Imaging Registry of Canada</brief_title>
  <acronym>CIROC</acronym>
  <official_title>Cardiovascular Imaging Registry of Canada</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alberta Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-site, multi-modality prospective observational clinical outcomes study focussed on
      the development of phenotype-dirven risk prediction modelling in patients with known or
      suspected cardiovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Cardiovascular Imaging Registry of Canada (CIROC) was conceived to provide a common
      standardized architecture for the collection of clinically reported imaging biomarkers,
      demographic information, resource utilization and clinical outcomes among patients referred
      to non-invasive cardiac imaging. The Registry was designed to assess the feasibility of
      implementing personalized care strategies through automated high quality data collection and
      patient engagement.

      The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however
      has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are
      engaged by automated, tablet-based tools to collect informed consent and deploy standardized
      patient health assessments. Standardized reporting of disease features are captured using
      bespoke reporting tools. All patients are prospectively followed for a period of 10-years
      using linkage to administrative health data, inclusive of ICD-coded events, laboratory test
      results, ECG and vital statistics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Anticipated">August 2030</completion_date>
  <primary_completion_date type="Anticipated">August 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiovascular outcomes (MACE)</measure>
    <time_frame>2024</time_frame>
    <description>Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Malignant arrhythmic events</measure>
    <time_frame>2024</time_frame>
    <description>Composite of sudden cardiac death or appropriate ICD shock</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart failure events</measure>
    <time_frame>2024</time_frame>
    <description>Composite of heart failure admission, death or need for transplantation / LVAD</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Atrial arrhythmic events</measure>
    <time_frame>2024</time_frame>
    <description>Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>2024</time_frame>
    <description>Death based on Vital Statistics Alberta and In-hospital coded death</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Patients with known or suspected cardiovascular disease</arm_group_label>
    <description>All patients with known or suspected cardiovascular disease are studied with a-priori stratification of specific disease-based cohorts.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diagnostic testing performed as per routine care</intervention_name>
    <arm_group_label>Patients with known or suspected cardiovascular disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients referred for hospital based cardiac imaging services are considered eligible
        and are routinely approached using automated patient engagement tools and consent
        management services.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients referred for hospital-based cardiac imaging services

        Exclusion Criteria:

          -  Failure or provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James White</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of Stephenson Cardiac Imaging Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James White</last_name>
    <phone>403-944-2805</phone>
    <email>jawhit@ucalgary.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandra Rivest</last_name>
    <phone>403-944-1961</phone>
    <email>sandra.rivest@ahs.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James A White, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Health Campus</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3M1M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James A White, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peter Lougheed Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James A White, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rockyview Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James A White, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 26, 2020</study_first_submitted>
  <study_first_submitted_qc>April 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>April 26, 2020</last_update_submitted>
  <last_update_submitted_qc>April 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>James White</investigator_full_name>
    <investigator_title>MD, FRCP(C) Director - Stephenson Cardiac Imaging Centre</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

